Roubaix Capital’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-111,815
Closed -$5.07M 61
2025
Q4
$5.07M Buy
111,815
+35,432
+46% +$1.3M 2.16% 22
2025
Q3
$2.33M Buy
+76,383
New +$2.35M 1.08% 41
2025
Q1
Sell
-88,650
Closed -$3.95M 67
2024
Q4
$3.95M Buy
88,650
+46,189
+109% +$2.07M 1.89% 29
2024
Q3
$1.85M Buy
+42,461
New +$1.6M 1.02% 43
2022
Q4
Sell
-38,479
Closed -$3.35M 60
2022
Q3
$3.35M Buy
38,479
+12,306
+47% +$1.29M 2.98% 15
2022
Q2
$2.98M Buy
26,173
+6,228
+31% +$715K 2.56% 16
2022
Q1
$2.58M Buy
+19,945
New +$2.87M 1.78% 27
2020
Q2
Sell
-13,478
Closed -$884K 63
2020
Q1
$884K Buy
+13,478
New +$1.07M 1.34% 37

Other funds holding OMCL

Roubaix Capital's OMCL Position: Q1 2026 in Review

Roubaix Capital sold out of Omnicell (OMCL) in Q1 2026, closing a stake of 111,815 shares — an estimated $5.07M sold.

Roubaix Capital first reported a position in OMCL in Q1 2020 and held it in 8 quarters. The position peaked at $5.07M in Q4 2025. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Roubaix Capital reported no remaining Omnicell position as of Q1 2026 after selling out during the quarter.
  • Roubaix Capital sold 111,815 Omnicell shares in Q1 2026, an estimated $5.07M.
  • Roubaix Capital first reported a position in Omnicell in Q1 2020 and held it in 8 quarters.
  • Roubaix Capital's Omnicell position peaked at $5.07M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Roubaix Capital's 13F filing for Q1 2026, filed 6 May 2026.